Last updated on March 2018

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy

Brief description of study

The purpose of the study is to evaluate the more efficient dose for the treatment of rhinitis/rhinoconjunctivitis against mite allergy

Detailed Study Description

Double blind placebo-controlled study. The subjects will receive medication during 4 months.

Clinical Study Identifier: NCT02661854

Find a site near you

Start Over